Vifor Pharma wins Pharma 4.0 award
Glattbrugg ZH – Vifor Pharma has won the 2018 Pharma 4.0 Award for innovation of the year in drug manufacturing. The pharmaceutical company from the Greater Zurich Area implemented an augmented reality system.
ETH holds on to top ranking
Zurich – The Federal Institute of Technology in Zurich (ETH) came in 11th place in this year’s Times Higher Education university ranking, meaning it remains the best university in continental Europe.
First crypto bank set for Switzerland
Zug – Prominent Swiss financial experts have raised 100 million francs to build a new bank. SEBA Crypto in Zug is designed to bridge the gap between traditional and crypto markets. The next step is acquiring a license.
Futurae Technologies wins investors
Zurich – Futurae Technologies has raised two million Swiss francs in a financing round. The spin-off from the Federal Institute of Technology in Zurich develops and sells secure authentication solutions.
Zurich sensor monitors growth of liver tissue outside of the body
Wädenswil ZH – Wyss Zurich is developing a perfusion system to allow the growth of healthy liver tissue outside of the body. C-CIT Sensors AG from the Greater Zurich Area is providing a sensor to monitor glucose levels crucial to the project.
Hystrix launches marketplace for medtech products
Biberist SO – Switzerland’s first digital marketplace for medical products, implants and services is soon to launch. Hystrix medical has secured well-known hospitals and suppliers – and is already planning to expand abroad.
Garaventa wins innovation award
Goldau SZ – This year’s main prize of the Central Switzerland Chamber of Industry and Commerce Innovation Award has been awarded to Garaventa AG. The ropeway manufacturer from Goldau impressed the jury with its cylindrical lift in Stoos.
Tamedia invests in Lykke
Zurich/Zug – Tamedia is investing in the Crypto Valley fintech startup Lykke. The media group also plans to make additional fintech investments in the future.
TOLREMO raises 9 million francs
Zurich – TOLREMO therapeutics AG has successfully raised 9 million Swiss francs in a Series A financing round. The biotech start-up from the Greater Zurich Area develops treatments to prevent drug resistance in cancer therapies.
Meet with an expansion expert
Our services are free of charge and include:
- Introduction to key contacts in industry, academia, and government
- Advice on regulatory framework, taxes, labor, market, and setting up a company
- Custom-made fact-finding visits, including office and co-working space